Hyperglycemia limits experimental aortic aneurysm progression

Journal of Vascular Surgery

Volumn 52, Issue 4, 2010, Pages 975-983

  Miyama, Noriyuki ^a   Dua, Monica M ^a   Yeung, Janice J ^a   Schultz, Geoffrey M ^a   Asagami, Tomoko ^a   Sho, Eiketsu ^a   Sho, Mien ^a   Dalman, Ronald L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; APOLIPOPROTEIN E; ELASTIN; GLUCOSE; INSULIN; PANCREATIC ELASTASE; THIOGLYCOLIC ACID; VASCULOTROPIN; ANTIDIABETIC AGENT; GELATINASE B; GLUCOSE BLOOD LEVEL; MMP9 PROTEIN, MOUSE; THIOGLYCOLIC ACID DERIVATIVE; VASCULOTROPIN A;

ABDOMINAL AORTA ANEURYSM; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; ELASTOLYSIS; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; INSULIN TREATMENT; MACROPHAGE MIGRATION; MALE; MOUSE; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; WEIGHT REDUCTION; ZYMOGRAPHY; ABDOMINAL AORTA; ANIMAL; BLOOD; BODY WEIGHT; C57BL MOUSE; CHEMICALLY INDUCED; COMPLICATION; DEFICIENCY; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODEL; DRUG EFFECTS; ECHOGRAPHY; GENETICS; KNOCKOUT MOUSE; MACROPHAGE; METABOLISM; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; TIME;

ANGIOTENSIN II; ANIMALS; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; APOLIPOPROTEINS E; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HYPOGLYCEMIC AGENTS; INSULIN; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC ELASTASE; PERITONITIS; THIOGLYCOLATES; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77957590318     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2010.05.086     Document Type: Article

References (40)

1. F.A. Lederle, G.R. Johnson, S.E. Wilson, E.P. Chute, D. Bandyk, and W.C. Krupski Prevalence and associations of abdominal aortic aneurysm detected through screening Ann Intern Med 126 1997 441 449
2. F.A. Lederle, G.R. Johnson, S.E. Wilson, E.P. Chute, R.J. Hye, and M.S. Makaroun The aneurysm detection and management study screening program: validation cohort and final results Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators Arch Intern Med 160 2000 1425 1430
3. A.R. Brady, F.G.R. Fowkes, R.M. Greenhalgh, J.T. Powell, C.V. Ruckley, and S.G. Thompson Risk factors for postoperative death following elective surgical repair of abdominal aortic aneurysm: results from the UK Small Aneurysm Trial Br J Surg 87 2000 742 749
4. P.E. Norman, K. Jamrozik, M.M. Lawrence-Brown, M.T.Q. Le, C.A. Spencer, and R.J. Tuohy Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm BMJ 329 2004 1259
5. M.T. Le, K. Jamrozik, T.M. Davis, and P.E. Norman Negative association between infra-renal aortic diameter and glycaemia: The Health In Men Study Eur J Vasc Endovasc Surg 33 2007 599 604
6. E. Mattes, T.M. Davis, D. Yang, D. Ridley, H. Lund, and P.E. Norman Prevalence of abdominal aortic aneurysms in men with diabetes Med J Aust 166 1997 630 633
7. A.R. Brady, S.G. Thompson, F.G.R. Fowkes, R.M. Greenhalgh, J.T. Powell UKSATP Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance Circulation 110 2004 16 21
8. K.K. Wu, and Y. Huan Diabetic atherosclerosis mouse models Atherosclerosis 191 2007 241 249
9. A. Daugherty, and L.A. Cassis Mouse models of abdominal aortic aneurysms Arterioscler Thromb Vasc Biol 24 2004 429 434 (Pubitemid 38326134)
10. J. Azuma, T. Asagami, R. Dalman, and P. Tsao Creation of murine experimental abdominal aortic aneurysms with elastase J Vis Exp 2009 29
11. E. Sho, M. Sho, H. Nanjo, K. Kawamura, H. Masuda, and R.L. Dalman Hemodynamic regulation of CD34+ cell localization and differentiation in experimental aneurysms Arterioscler Thromb Vasc Biol 24 2004 1916 1921
12. M.M. Tedesco, M. Terashima, F.G. Blankenberg, Z. Levashova, J.M. Spin, and M.V. Backer Analysis of in situ and ex vivo vascular endothelial growth factor receptor expression during experimental aortic aneurysm progression Arterioscler Thromb Vasc Biol 29 2009 1452 1457
13. K. Yoshimura, H. Aoki, Y. Ikeda, K. Fujii, N. Akiyama, and A. Furutani Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase Nat Med 11 2005 1330 1338
14. B. Martin-McNulty, J. Vincelette, R. Vergona, M.E. Sullivan, and Y.-X. Wang Noninvasive measurement of abdominal aortic aneurysms in intact mice by a high-frequency ultrasound imaging system Ultrasound Med Biol 31 2005 745 749
15. C. Barisione, R. Charnigo, D. Howatt, J. Moorleghen, D. Rateri, and A. Daugherty Rapid dilation of the abdominal aorta during infusion of angiotensin II detected by noninvasive high-frequency ultrasonography J Vasc Surgery 44 2006 372 376
16. S. Anidjar, J.L. Salzmann, D. Gentric, P. Lagneau, J.P. Camilleri, and J.B. Michel Elastase-induced experimental aneurysms in rats Circulation 82 1990 973 981
17. Y. Gong, E. Hart, A. Shchurin, and J. Hoover-Plow Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice J Clin Invest 118 2008 3012 3024
18. C. Cursiefen, L. Chen, L. Borges, D. Jackson, J. Cao, and C. Radziejewski VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment J Clin Invest 113 2004 1040 1050
19. K. Moulton, K. Vakili, D. Zurakowski, M. Soliman, C. Butterfield, and E. Sylvin Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis Proc Natl Acad Sci USA 100 2003 4736 4741
20. S. Shiraya, T. Miyake, M. Aoki, F. Yoshikazu, S. Ohgi, and M. Nishimura Inhibition of development of experimental aortic abdominal aneurysm in rat model by atorvastatin through inhibition of macrophage migration Atherosclerosis 202 2009 34 40
21. T. Tsuruda, J. Kato, K. Hatakeyama, K. Kojima, M. Yano, and Y. Yano Adventitial mast cells contribute to pathogenesis in the progression of abdominal aortic aneurysm Circ Res 102 2008 1368 1377
22. M.A. Creager, T.F. Luscher, F. Cosentino, and J.A. Beckman Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I Circulation 108 2003 1527 1532 (Pubitemid 37176462)
23. A. Ceriello, and E. Motz Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited Arterioscler Thromb Vasc Biol 24 2004 816 823
24. E. Choke, M.M. Thompson, J. Dawson, W.R.W. Wilson, S. Sayed, and I.M. Loftus Abdominal aortic aneurysm rupture is associated with increased medial neovascularization and overexpression of proangiogenic cytokines Arterioscler Thromb Vasc Biol 26 2006 2077 2082
25. D.R. Holmes, S. Liao, W.C. Parks, and R.W. Thompson Medial neovascularization in abdominal aortic aneurysms: a histopathologic marker of aneurysmal degeneration with pathophysiologic implications J Vasc Surg 21 1995 761 771
26. D. Ceradini, D. Yao, R. Grogan, M. Callaghan, D. Edelstein, and M. Brownlee Decreasing intracellular superoxide corrects defective ischemia-induced new vessel formation in diabetic mice J Biol Chem 283 2008 10930 10938
27. H. Thangarajah, D. Yao, E. Chang, Y. Shi, L. Jazayeri, and I. Vial The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues Proc Natl Natl Acad Sci USA 106 2009 13505 13510
28. G. Onuta, P. Westerweel, A. Zandvoort, M. van Riezen, J. Rozing, and J.-L. Hillebrands Angiogenic sprouting from the aortic vascular wall is impaired in the BB rat model of autoimmune diabetes Microvasc Res 75 2008 420 425
29. D.R. Cha, Y.S. Kang, S.Y. Han, Y.H. Jee, K.H. Han, and J.Y. Han Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats J Endocrinol 183 2004 183 194
30. K. Miyamoto, S. Khosrof, S.-E. Bursell, Y. Moromizato, L.P. Aiello, and Y. Ogura Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1) Am J Pathol 156 2000 733 739
31. Y. Carmi, E. Voronov, S. Dotan, N. Lahat, M.A. Rahat, and M. Fogel The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis J Immunol 183 2009 4705 4714
32. J. Waltenberger, J. Lange, and A. Kranz Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: a potential predictor for the individual capacity to develop collaterals Circulation 102 2000 185 190
33. V. Tchaikovski, S. Olieslagers, F.D. Bohmer, and J. Waltenberger Diabetes mellitus activates signal transduction pathways resulting in vascular endothelial growth factor resistance of human monocytes Circulation 120 2009 150 159
34. G.M. Longo, X. Wanfen, T.C. Greiner, Z. Yong, N. Fiotti, and B.T. Baxter Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms J J Clin Invest 110 2002 625
35. W. Xiong, R. Knispel, J. MacTaggart, T. Greiner, S. Weiss, and B.T. Baxter Membrane-type 1 matrix metalloproteinase regulates macrophage-dependent elastolytic activity and aneurysm formation in vivo J Biol Chem 284 2009 1765 1771
36. W.D. McMillan, N.A. Tamarina, M. Cipollone, D.A. Johnson, M.A. Parker, and W.H. Pearce Size matters: the relationship between MMP-9 expression and aortic diameter Circulation 96 1997 2228 2232
37. J. Golledge, M. Karan, C.S. Moran, J. Muller, P. Clancy, and A.E. Dear Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte matrix interactions Eur Heart J 29 2008 665 672
38. K. Maruyama, J. Asai, M. Ii, T. Thorne, D.W. Losordo, and P.A. D'Amore Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing Am J Pathol 170 2007 1178 1191
39. A. Festa, R. D'Agostino Jr, L. Mykkanen, R.P. Tracy, D.J. Zaccaro, and C.N. Hales Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance : The Insulin Resistance Atherosclerosis Study (IRAS) Arterioscler Thromb Vasc Biol 19 1999 562 568
40. F. Zhang, K.C. Kent, D. Yamanouchi, Y. Zhang, K. Kato, and S. Tsai Anti-receptor for advanced glycation end products therapies as novel treatment for abdominal aortic aneurysm Ann Surg 250 2009 416 423